Biología Molecular del Cáncer-IBiS

Carnero's lab focuses on the search and characterization of new biomarkers in cancer. @ibis_sevilla @CSIC @HospitalUVRocio @unisevilla @CIBERONC @ContraCancerEs

[MDPI @MDPIOpenAccess]

The European Union (EU) has a range of initiatives dedicated to establishing Open Access as the norm in scientific publishing.

Plan S and Horizon Europe both mandate that funded research be made fully Open Access.

Learn more: https://t.co/tK8dhgj9wp

#MDPI #OpenAccess

[Biología Molecular del Cáncer-IBiS @bmc_lab]

📷
Emerging Roles of Hepatocellular Carcinoma Gene Signatures in Prognosis and Immunotherapy: Challenges and Opportunities

Amany Wahb, et al
Gene Expr. 2026;25(2):e00073.
doi:10.14218/GE.2025.00073

[Biología Molecular del Cáncer-IBiS @bmc_lab]

Ayer nuestro grupo participó en la Feria de la Ciencia de la ciencia con un taller titulado "Detectives del ADN: ¿Qué ocultan las células?"

@ibis_sevilla
@CSIC

#24FeriaCiencia

[dra fermdo @fernandamdo]

Hoy voy a contarles de las verdaderas razones del envejecimiento cerebral acelerado, es este paper que salió en abril de 2026 y que todo el mundo está citando pero casi nadie lo está explicando.

[Cancers MDPI @Cancers_MDPI]

📄New #Editor’s Choice!
“#ArtificialIntelligence-Driven Personalization in #BreastCancer Screening: From Population Models to Individualized Protocols” by Filippo Pesapane et al.
🔓Read it free here: https://t.co/wxLN62ekMc

[Biología Molecular del Cáncer-IBiS @bmc_lab]

Targeting Histone Modifications in Colorectal Cancer: Therapeutic Potential of Epigenetic Modifiers on Acetylation, Methylation and Phosphorylation

by Abdeslam Jaafari

Gene Expression 2026;25(1):e00046

doi: 10.14218/GE.2025.00046

[Asociación Española Contra el Cáncer @ContraCancerEs]

¿Sabes realmente qué es el cáncer? ¿Por qué las células de nuestro cuerpo empiezan a crecer y crecer? 🔬El Dr. Marcos Malumbres, investigador en @VHIO nos ayuda a entenderlo #InvestigandoenCáncer

[Cancers MDPI @Cancers_MDPI]

📢NEW #SpecialIssue ON “Chronic Lymphocytic #Leukemia and Indolent B-Cell #Lymphomas: Clonal Evolution, Microenvironment, and Immune Remodeling.”
👨‍⚕️Guest Editor: Prof. Dr. Franco Fais @UniGenova
➡Look forward to receiving your submission at: https://t.co/EcO48dVfls

[Cancers MDPI @Cancers_MDPI]

🔎A study published in #CancersMDPI claims that international guidelines recommending against #breast #thermography are based on obsolete evidence and should be updated.
✍by Ane Goñi-Arana, Jorge Pérez-Martín and Francisco Javier Díez. @UNED
🔗Full paper: https://t.co/0fEhuwG6uW

[Cancers MDPI @Cancers_MDPI]

🌟Calling for Papers🌟
📚 New #SpecialIssue: Cancer and the #Brain: Brain and Tumor Interplay, the Nervous System's Vulnerabilities and Therapeutic Opportunities
👨‍🔬Guest Editor: Dr. Sylvia C. Kurz @YaleMed
🔗Find Out More: https://t.co/qe4RKJTWon

[Cancers MDPI @Cancers_MDPI]

📢Call for Papers! New #SpecialIssue “Metabolomic #Biomarkers for Cancers” edited by Prof. Dr. Emirhan Nemutlu & Dr. Burak Derkuş, is now open for submissions! 👏
🧐Discover More: https://t.co/0EBa1cCmej

🍀Please submit your manuscript and join this transformative journey.

[MDPI @MDPIOpenAccess]

The Journal Relations Specialists (JRS) team are MDPI’s primary ambassadors to academic stakeholders.

In 2025, JRS engagement reached a new milestone: more than 16,000 meetings with academics worldwide.

Learn more: https://t.co/jsTh9sB6MJ

[Cancers MDPI @Cancers_MDPI]

📢 New #SpecialIssue Now Open for Submissions!
"Advances in Cancer #TargetedTherapy"
Edited by: Dr. Ponniah Selvakumar @JeffersonUniv
⏰ Deadline: 30 September 2026
Submit your manuscript and join this transformative journey ➡️ https://t.co/ODlfBRhGDa

[Biología Molecular del Cáncer-IBiS @bmc_lab]

Enhorabuena a nuestra Compañera Asuncion Espinosa por obtener el Reconocimiento AECC 2025 Talento Emergente en Investigación de la Fundación Científica AECC.

[Asociación Española Contra el Cáncer @ContraCancerEs]

III Encuentro de Investigadores de @contracancerINV @ContraCancerEs
Un espacio para dialogar, compartir conocimiento y conectar esfuerzos que impulsan la ciencia oncológica en nuestro país.
#InvestigandoenCáncer

[Cancers MDPI @Cancers_MDPI]

📢 New #SpecialIssue "Exploring the Processes of Biochemical, Cellular and Molecular Drivers of Cancer Cell and Emerging Therapies" guest edited by Dr. Amit Kunwar from @IndiaBARC is now open for submissions!

🔍 Learn more & submit your manuscript: https://t.co/5Bjsj8oj3v

[Cancers MDPI @Cancers_MDPI]

📢We're excited to share the #SpecialIssue "Role of #TP53 Mutation in Cancer" edited by Dr. Naoyuki Iwahashi (#Wakayama Medical University), now open for submissions! 👏
🗓️Submission Deadline: 31 August 2026
📌Find more details here: https://t.co/vgupNrW7Jv

[Contra el Cáncer Investigación @contracancerINV]

¡Hasta el año que viene! 💚